Great Lakes Advisors’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
MF
VI
FLAM
AAM
RSCM
Great Lakes Advisors's XENT Position: Q3 2021 in Review
Great Lakes Advisors sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 265,645 shares — an estimated $4.54M sold.
Great Lakes Advisors first reported a position in XENT in Q1 2019 and held it in 8 quarters. The position peaked at $5.72M in Q4 2020. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.
- Great Lakes Advisors reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
- Great Lakes Advisors sold 265,645 Intersect ENT, Inc shares in Q3 2021, an estimated $4.54M.
- Great Lakes Advisors first reported a position in Intersect ENT, Inc in Q1 2019 and held it in 8 quarters.
- Great Lakes Advisors's Intersect ENT, Inc position peaked at $5.72M in Q4 2020.
- 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.
Based on Great Lakes Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.